PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of PepGen, Inc. (NASDAQ:PEPG) have earned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $11.50.

Several research analysts have recently commented on PEPG shares. HC Wainwright reissued a “buy” rating on shares of PepGen in a report on Thursday, May 21st. Wedbush lowered their target price on shares of PepGen from $5.00 to $4.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Wall Street Zen upgraded shares of PepGen from a “sell” rating to a “hold” rating in a research report on Sunday, June 7th. Craig Hallum initiated coverage on shares of PepGen in a report on Tuesday, June 16th. They issued a “buy” rating and a $11.00 price target on the stock. Finally, Weiss Ratings cut shares of PepGen from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, June 2nd.

Hedge Funds Weigh In On PepGen

Several institutional investors have recently modified their holdings of PEPG. Rangeley Capital LLC increased its position in shares of PepGen by 133.3% during the 2nd quarter. Rangeley Capital LLC now owns 35,000 shares of the company’s stock valued at $39,000 after purchasing an additional 20,000 shares during the last quarter. Marshall Wace LLP purchased a new stake in PepGen in the second quarter worth approximately $44,000. Burkehill Global Management LP bought a new position in PepGen during the third quarter valued at approximately $46,000. Militia Capital Partners LP bought a new stake in shares of PepGen in the 3rd quarter worth approximately $72,000. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of PepGen by 94.9% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 11,202 shares of the company’s stock worth $73,000 after acquiring an additional 5,453 shares during the last quarter. 58.01% of the stock is currently owned by institutional investors.

PepGen Stock Performance

PepGen stock opened at $2.12 on Wednesday. PepGen has a fifty-two week low of $1.01 and a fifty-two week high of $7.80. The stock has a market cap of $146.64 million, a P/E ratio of -1.21 and a beta of 1.88. The firm’s fifty day moving average price is $1.74 and its 200-day moving average price is $3.49.

PepGen (NASDAQ:PEPG) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.05. Sell-side analysts predict that PepGen will post -1.2 earnings per share for the current year.

PepGen Company Profile

PepGen, Inc (NASDAQ: PEPG) is a clinical-stage biotechnology company headquartered in San Diego, California. The company is developing precision gene editing therapies to address rare genetic diseases by combining advanced prime editing modalities with proprietary delivery technologies. PepGen’s platform is designed to achieve targeted and durable correction of disease-causing mutations in vivo, with the goal of providing long-lasting therapeutic benefit after a single administration.

The company’s lead development programs include PPG-001 for mucopolysaccharidosis type II (Hunter syndrome) and PPG-002 for mucopolysaccharidosis type I (Hurler syndrome).